Molecular Pathology of Rare Diseases
MolPath-RD
Klinikum der Universität München
Múnich, AlemaniaPublications in collaboration with researchers from Klinikum der Universität München (2)
2024
-
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
EMBO Molecular Medicine, Vol. 16, Núm. 7, pp. 1657-1674
2020
-
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
Advances in Therapy, Vol. 37, Núm. 5, pp. 1724-1736